A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

Publication | Open Access

DOI Full Paper Access

556

Citations

References

2014

Year

Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek, Ángel Cequier, Didier Carrié, Andrés Íñiguez, Marcello Dominici, René J. van der Schaaf, Michael Haude, Luc Wasungu,

The Lancet

Percutaneous Coronary InterventionAbsorb IiEndovascular TechniqueCardiovascular DiseaseAtherosclerosisCoronary Artery DiseaseOutcomes ResearchSurgeryAcute Myocardial InfarctionBioresorbable Everolimus-eluting ScaffoldMedicineCardiologyProcedural Secondary OutcomesCoronary Heart Disease